The levels of circulating vascular endothelial growth factor and soluble Flt-1 in pregnancies complicated by preeclampsia

Journal of Korean Medical Science

Volumn 22, Issue 1, 2007, Pages 94-98

  Eun, Sung Lee ^a   Oh, Min Jeong ^a,c   Jae, Won Jung ^a   Lim, Ji Eun ^a   Seol, Hyun Joo ^a   Lee, Kyung Ju ^b   Kim, Hai Joong ^a  

^a Korea University College of Medicine   (South Korea)

^b CHA University   (South Korea)

^c Korea University College of Medicine   (South Korea)

Author keywords

Pre eclampsia; sFlt 1; Vascular endothelial growth factor; Vasular endothelial growth factor receptor 1

Indexed keywords

EID: 33847159865     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2007.22.1.94     Document Type: Article

References (29)

1. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672-83.
2. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-58.
3. Lee GS, Lee JK, Han WS, Lee Y, Kim SJ, Rha JG, Kim SP, Namkoong SE. The expression of vascular endothelial growth factor, platelet-derived growth factor and intercellular adhesion molecule in severe preeclamptic placenta. Korean J Obstet Gynecol 2003; 46: 606-11.
4. Luttun A, Carmeliet P. Soluble VEGF receptor Flt-1: the elusive preeclampsia factor discovered? J Clin Invest 2003; 111: 600-2.
5. Jelkmann W. Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin Chem 2001; 47: 617-23.
6. Sugimoto H, Hamano Y, Charytan D, Cosrove D, Kieran M, Sudhakar A, Kalluri R. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 2003; 278: 12605-8.
7. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13: 18-32.
8. Chaiworapongsa T, Romero R, Espinoza J, Bujold E, Mee Kim Y, Gonclaves LF, Gomez R, Edwin S. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophsiology of preeclampsia. Am J Obstet Gynecol 2004; 190: 1541-50.
9. Kupferminc MJ, Daniel Y, Englender T, Baram A, Many A, Jaffa AJ, Gull I, Lessing JB. Vascular endothelial growth factor is increased in patients with preeclampsia. Am J Reprod Immunol 1997; 38: 302-6.
10. Cho YK, Min HJ, Park KH, Choi H, Kim BR, Lee HK. Serum concentration of vascular endothelial growth factor in preeclamptic women. Korean J Obstet Gynecol 2000; 43: 1967-71.
11. Lee KJ, Oh MJ, Kim HJ, Kim SH, Lee JK, Hur JY, Saw HS, Park YK. Correlation of serum vascular endothelial growth factor and matrix metalloproteinase-2 in patients complicated with preeclampsia and normotensive pregnant women. Korean J Obstet Gynecol 2005; 48: 29-35.
12. Polliotti BM, Fry AG, Saller DN, Mooney RA, Cox C, Miller RK. Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early onset preeclampsia. Obstet Gynecol 2003; 101: 1266-74.
13. Koga K, Osuga Y, Yoshino O, Hirota Y, Ruimeng X, Hirata T, Takeda S, Yano T, Tsutsumi O, Taketani Y. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab 2003; 88: 2348-51.
14. Brockelsby JC, Hayman R, Ahmed A, Warren A, Johnson I, Baker P. VEGF via VEGF receptor-1 (Flt-1) mimics preeclamptic plasma in inhibiting uterine blood vessel relaxation in pregnancy: implications in the pathogenesis of preeclampsia. Lab Invest 1999; 79: 1101-11.
15. Levine RJ, Ewell MG, Hauth JC, Curet LB, Catalano PM, Morris CD, Choudhary G, Sibai BM. Should the definition of preeclampsia include a rise in diastolic blood pressure of >/=15 mm Hg to a level <0 mm Hg in association with proteinuria? Am J Obstet Gynecol 2000; 183: 787-92.
16. Oh MJ, Shin JC, Popek EJ. Vascular endothelial growth factor expression in patients complicated preeclampsia. Korean J Obstet Gynecol 2001; 44: 1877-82.
17. Lyall F, Greer IA, Boswell F, Fleming R. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in preeclampsia. Br J Obstet Gynecol 1997; 104: 223-8.
18. Reuvekamp A, Velsing-Aarts FV, Poulina IEJ, Capello JJ, Duits AJ. Selective deficit of angiogenic growth factor characterizes pregnancies complicated by preeclampsia. Br J Obstet Gynecol 1999; 106: 1019-22.
19. Baker PN, Krasnow J, Roberts JM, Yeo KT. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol 1995; 86: 815-21.
20. Sharkey AM, Cooper JC, Balmforth JR, Mclaren J, Clark DE, Charnock-Jones DS, Morris NH, Smith SK. Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and pregnancies complicated by preeclampsia. Eur J Clin Invest 1996; 26: 1182-5.
21. Brockelsby JC, Anthony FW, Johnson IR, Wheeler T, Baker PN. Increased serum vascular endothelial growth factor concentrations in pre-eclampsia. Hypertens Pregnancy 1998; 17: 283-90.
22. Shibuya M. Role of VEGF-flt receptor system in normal and tumor angiogenesis. Adv Cancer Res 1995; 67: 281-316.
23. Brockelsby JC, Anthony FW, Johnson IR, Baker PN. The effects of vascular endothelial growth factor on endothelial cells: A potential role in preeclampsia. Am J Obstet Gynecol 2000; 182: 176-83.
24. Cho YK, Lee HK. The effect of VEGF on endothelial cells in pathogenesis of preeclampsia. Korean J Obstet Gynecol 2002; 45: 1354-9.
25. Hood JD, Meininger CJ, Ziche M, Granger HJ. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol 1998; 274: 1054-8.
26. Ashworth JR, Warren AY, Johnson IR, Baker PN. Plasma from preeclamptic women and functional change in myometrial resistance arteries. Br J Obstet Gynecol 1998; 105: 459-61.
27. Anthony FW, Evans PW, Wheeler T, Wood PJ. Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins. Ann Clin Biochem 1997; 34: 276-80.
28. 2-macroglobulin with vascular endothelial growth factor. J Biol Chem 2000; 275: 26806-11.
29. 2-macroglobulin on VEGF-induced endothelin-1 upregulation in human umbilical vein endothelial cells. Placenta 2006; 27: A50.